Hematologic malignancies: An opportunity for targeted drug therapy

J. L. Gabrilove

doi:10.1634/theoncologist.6-suppl_5-1

Hematologic malignancies: An opportunity for targeted drug therapy

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Oncologist
Volume	6
Issue number	SUPPL. 5
DOIs	https://doi.org/10.1634/theoncologist.6-suppl_5-1
State	Published - 2001
Externally published	Yes

Keywords

Angiogenesis
Cancer
Chemotherapy
Leukemia
Myelodysplastic syndromes
Thrombocytopenia

Access to Document

10.1634/theoncologist.6-suppl_5-1

Cite this

@article{3b2923ca3e0449639e527065d6d2a9aa,

title = "Hematologic malignancies: An opportunity for targeted drug therapy",

keywords = "Angiogenesis, Cancer, Chemotherapy, Leukemia, Myelodysplastic syndromes, Thrombocytopenia",

author = "Gabrilove, {J. L.}",

year = "2001",

doi = "10.1634/theoncologist.6-suppl_5-1",

language = "English",

volume = "6",

pages = "1--3",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "SUPPL. 5",

}

TY - JOUR

T1 - Hematologic malignancies

T2 - An opportunity for targeted drug therapy

AU - Gabrilove, J. L.

PY - 2001

Y1 - 2001

KW - Angiogenesis

KW - Cancer

KW - Chemotherapy

KW - Leukemia

KW - Myelodysplastic syndromes

KW - Thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=0035158251&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.6-suppl_5-1

DO - 10.1634/theoncologist.6-suppl_5-1

M3 - Article

C2 - 11700385

AN - SCOPUS:0035158251

SN - 1083-7159

VL - 6

SP - 1

EP - 3

JO - Oncologist

JF - Oncologist

IS - SUPPL. 5

ER -